Danaher Corporation $DHR Stock Position Raised by Whittier Trust Co.

Whittier Trust Co. increased its stake in Danaher Corporation (NYSE:DHR) by 7.5% during the first quarter, HoldingsChannel.com reports. The fund owned 314,938 shares of the conglomerate’s stock after buying an additional 22,044 shares during the period. Whittier Trust Co.’s holdings in Danaher were worth $60,506,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of DHR. Bank Pictet & Cie Europe AG boosted its holdings in shares of Danaher by 25.4% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock worth $83,895,000 after buying an additional 74,301 shares during the period. Maxi Investments CY Ltd acquired a new stake in shares of Danaher during the third quarter valued at approximately $3,251,000. Defender Capital LLC. purchased a new stake in shares of Danaher in the 4th quarter valued at approximately $35,715,000. Northwestern Mutual Wealth Management Co. lifted its position in shares of Danaher by 303.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after acquiring an additional 186,584 shares in the last quarter. Finally, CIBC Bancorp USA Inc. acquired a new position in Danaher in the 3rd quarter worth approximately $17,480,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Down 0.0%

DHR opened at $197.85 on Monday. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The business has a 50-day moving average of $179.01 and a 200-day moving average of $200.34. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The company has a market capitalization of $140.03 billion, a PE ratio of 38.27, a price-to-earnings-growth ratio of 2.52 and a beta of 0.79.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same quarter in the previous year, the business posted $1.88 EPS. The firm’s quarterly revenue was up 3.7% compared to the same quarter last year. Equities research analysts forecast that Danaher Corporation will post 8.44 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is currently 30.95%.

Analyst Ratings Changes

DHR has been the topic of several research analyst reports. Citigroup initiated coverage on shares of Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price objective on the stock. Guggenheim reduced their target price on Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. TD Cowen decreased their target price on Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Wells Fargo & Company dropped their price target on Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 22nd. Finally, The Goldman Sachs Group reduced their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Monday, April 13th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $233.61.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.